Compounds, compositions, and methods for the treatment of inflammatory, degenerative, and neurodegenerative diseases
US-2024409487-A1 · Dec 12, 2024 · US
US2020040017A1 · US · A1
| Field | Value |
|---|---|
| Publication number | US-2020040017-A1 |
| Application number | US-201816486295-A |
| Country | US |
| Kind code | A1 |
| Filing date | Feb 14, 2018 |
| Priority date | Feb 15, 2017 |
| Publication date | Feb 6, 2020 |
| Grant date | — |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
A method of preparing a solid-supported phospholipid bilayer is provided. The method includes a) a first step of providing a solution comprising a bicellar mixture of a long-chain phospholipid and a short-chain phospholipid; b) at least one second step of decreasing the temperature of the solution to below 0° C., increasing the temperature to above room temperature and causing the solution to be blended; and c) a third step of depositing the solution obtained after the second step on a surface of a support, wherein the concentration of the long-chain phospholipid in the solution is at most 0.1 mg/mL, for obtaining a solid-supported phospholipid bilayer. A solid-supported phospholipid layer obtained by the method as defined above is also provided.
Opening claim text (preview).
1 . A method of preparing a solid-supported phospholipid bilayer, the method comprising: a) a first step of providing a solution comprising a bicellar mixture of a long-chain phospholipid and a short-chain phospholipid; b) at least one second step of decreasing the temperature of the solution to below 0° C., increasing the temperature to above room temperature and causing the solution to be blended; and c) a third step of depositing the solution obtained after the second step on a surface of a support, wherein a concentration of the long-chain phospholipid in the solution is at most 0.1 mg/mL, for obtaining a solid-supported phospholipid bilayer. 2 . The method of claim 1 , wherein the long-chain phospholipid is a phospholipid comprising two fatty acid residues, wherein each of the fatty acid residues has more than 10 carbons. 3 . The method of claim 1 , wherein at least one of the long-chain phospholipid and the short-chain phospholipid is a phosphatidylcholine. 4 . The method of claim 1 , wherein the long-chain phospholipid has a gel-to-fluid-phase transition temperature of below 0° C. 5 . The method of claim 1 , wherein the short-chain phospholipid is a phospholipid comprising two fatty acid residues, wherein each of the fatty acid residues has at most 10 carbons. 6 . (canceled) 7 . (canceled) 8 . The method of claim 1 , wherein at least one of the long-chain phospholipid and the short-chain phospholipid comprises an unsaturated fatty acid residue. 9 . (canceled) 10 . (canceled) 11 . The method of claim 1 , wherein the short-chain phospholipid is 1,2-dihexyanoyl-sn-glycero-3-phosphocholine and the long-chain phospholipid is 1,2-dioleoyl-sn-glycero-3-phosphocholine. 12 . The method of claim 1 , wherein the concentration of the long-chain phospholipid in the solution of the third step is below 0.05 mg/mL. 13 . The method of claim 1 , wherein the long-chain phospholipid and the short-chain phospholipid are provided in a molar ratio of about 1:0.02 to about 1:5. 14 . The method of claim 1 , wherein the solution of the second step after blending is diluted in order to obtain the concentration of the long-chain phospholipid in the solution being at most 0.1 mg/mL. 15 . The method of claim 1 , wherein the solvent used to make the solution is a water-based buffer solution. 16 . The method of claim 1 , wherein the support is an inorganic material. 17 . The method of claim 1 , wherein the surface of the support is substantially planar. 18 . The method of claim 1 , wherein the surface of the support is nanostructured. 19 . (canceled) 20 . The method of claim 1 , wherein in the third step, the bicellar mixture ruptures in order to obtain the solid-supported phospholipid bilayer. 21 . The method of claim 1 , wherein decreasing the temperature of the solution to below 0° C. in the at least one second step comprises decreasing the temperature of the solution to below −10° C. 22 . The method of claim 1 , wherein increasing the temperature to above room temperature in the at least one second step comprises increasing the temperature to above 30° C. 23 - 25 . (canceled) 26 . The method of claim 1 , wherein the second step is repeated for about at least 2 times. 27 . The method of claim 1 , wherein the obtained solid-supported phospholipid bilayer is a planar phospholipid bilayer on the support. 28 . A solid-supported phospholipid bilayer obtained by the method of claim 1 . 29 - 32 . (canceled)
for applying particular liquids or other fluent materials · CPC title
Organic solvent (B05D2401/21 takes precedence) · CPC title
Other inorganic substrates, e.g. ceramics, silicon · CPC title
Manufacture or treatment of nanostructures · CPC title
Adducts, complexes, salts of phosphatides · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.